E

Encube Ethicals Ltd.

NSE & BSE
unknown

TBA

TBA

1 Shares

TBA

₹1

Financial Summary

Consolidated(in ₹ million)
ParticularsFY 2025-26FY 2024-25
18,48713,448
631242
19,11813,690
11,8489,118
5,9023,342
4,3672,496

Subscription Details

Subscription data not yet available

IPO Timeline

IPO Offer Start

TBA

IPO Offer Ends

TBA

TBA

Promoters

Mehul Madhusudan Shah

Book Running Lead Managers

JM Financial Ltd.Axis Capital Ltd.Kotak Mahindra Capital Co Ltd

Promoter Shareholding

Pre-IPO

80.91%

Promoter stake

IPO Registrar

MUFG Intime India Pvt Ltd.

About the Company

We are a global pharmaceutical formulations platform with deep domain expertise in technically complex topical and transdermal dosage forms, serving 50 countries including regulated markets such as the United States, UK and Europe, and India as of March 31, 2026. We operate through three business verticals: our global generics business (“Global Generics”), global contract development and manufacturing organization (“CDMO”) business (“Global CDMO”) and our India branded formulations business (“India Branded Formulations”), each serving different end markets and customer segments supported by a unified platform of R&D, manufacturing infrastructure, quality management systems and supply chain. The strength of this integrated platform is reflected across our market position, customer relationships and financial performance

IPO FAQs

The for the Encube Ethicals Ltd. IPO is 1 shares, which is also the minimum order quantity — you have to apply for at least 1 shares, and in multiples of 1 beyond that.

MUFG Intime India Pvt Ltd. is the for the Encube Ethicals Ltd. IPO.

The registrar processes the , refunds and the credit of shares to your demat account, so allotment-status queries go to them — phone +91 810 811 8484 and email rnt.helpdesk@in.mpms.mufg.com.

Encube Ethicals Ltd. IPO shares are proposed to be listed on BSE and NSE.

Each Encube Ethicals Ltd. share has a of ₹1.

Face value is the nominal value recorded in the company's books and is separate from the issue price you pay.

held 80.91% of Encube Ethicals Ltd. before the IPO.

JM Financial Ltd., Axis Capital Ltd. and Kotak Mahindra Capital Co Ltd are the for the Encube Ethicals Ltd. IPO.

Pre-apply means placing your Encube Ethicals Ltd. application before the subscription window actually opens. The bid is held and forwarded to the exchange on the opening day, so you don't have to submit it in the rush of the first morning.

Applying early doesn't improve your chances — when an issue is oversubscribed, the for investors is decided by a lottery, not by who applied first. Your money is only blocked once the application reaches the exchange.

You can apply in the Encube Ethicals Ltd. IPO online using either UPI or ASBA as the payment method. ASBA applications are made through the net banking of a bank account that supports IPO applications — the bank blocks the amount in your account instead of debiting it. UPI applications are offered by brokers that don't provide banking services: you enter your UPI ID and then approve the mandate request in your UPI app.

Either route needs a demat account. You bid for at least one lot, at a price within the or at the cut-off price, and the money stays blocked in your bank account until the is finalised.

Your broker or bank confirms the bid once it has been submitted to the exchange, usually within a few minutes during the bidding window. A UPI application only goes live after you approve the mandate request — ignore it and the bid lapses, even though it looks placed.

You can check the Encube Ethicals Ltd. bid independently on the NSE or BSE IPO bid-verification page a day after applying. An ASBA application also shows up as a blocked amount in your bank statement.